Delivery Order SPE2DB22D1106-SPE2DB25FERB1
Award Date 6/1/25
Potential Completion Date 6/2/25
Potential Value $5.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,277.55 to AmerisourceBergen Drug Corp for Barhemsys 5 mg/2 ml vials on August 8, 2025, with completion targeted for August 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction within AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Barhemsys 5 mg/2 ml vials with a ceiling value of $1,198.52. This is a firm fixed-price delivery order with no set-aside designation, executed competitively under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999.99 million and extends through December 2026. The product will be delivered to the...
- The Defense Logistics Agency awarded a $2,221.96 delivery order to AmerisourceBergen Drug Corp for BARHEMSYS 5 mg/2 ml vials on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed price, non-set-aside contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,024.38 firm fixed-price delivery order is for the supply of the medication BARHEMSYS 5 MG/2 ML VIAL 2ML. The contract has an ultimate completion date of August 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication BARHEMSYS 10 MG/4 ML VIAL 4ML. The contract has a ceiling value of $5,316.04 and an ultimate completion date of April 22, 2025. This contract is not designated as a set-aside and represents an open competition. AmerisourceBergen Drug Corp is the prime contractor and holds a significant Indefinite...
- This federal contract award, valued at $1,462.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product, with a completion date of December 13, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4567212297 - BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price of $1,310.68 and has a completion date of February 11, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- The Defense Logistics Agency awarded a $2,554.97 delivery order to AmerisourceBergen Drug Corp for BARHEMSYS 10 mg/4 ml vials on October 17, 2025, with an ultimate completion date of October 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. BARHEMSYS (amisulpride) is an atypical antipsychotic medication used in clinical settings to treat...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division for the procurement of BARHEMSYS 10 MG/4 ML VIAL 4ML, a pharmaceutical product. The contract has a ceiling value of $19,331.43 and a period of performance ending on April 25, 2024. This award is made under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999.00 and runs...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $43,377.81 to AmerisourceBergen Drug Corp on August 18, 2025, with completion expected by August 19, 2025. This firm fixed-price, competitively awarded delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $1 billion and extends through December 2026. The delivery order represents a child contract...